ANVS

ANVS

USD

Annovis Bio Inc. Common Stock

$1.890-0.060 (-3.077%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.950

Máximo

$2.029

Mínimo

$1.890

Volumen

0.22M

Fundamentos de la Empresa

Capitalización de Mercado

46.2M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.60M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $1.11Actual $1.890Máximo $8.93

Noticias Relacionadas

GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Ver más
Annovis Announces $6 Million Registered Direct Offering of Common Stock
GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Ver más
Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment
GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

Ver más
Annovis Appoints Mark Guerin as Chief Financial Officer